ET NOW analysts had anticipated a profit of Rs 400 crore for the December quarter.

At the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the...

The approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.

The company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said.

"Cipla FY16 guidance of 20-22 per cent revenue growth and 100 to 150 bps margin improvement for this year does not include InvaGen"

The deal closure, that involved approvals from the US regulatory agencies, will see Cipla vault its sales from that market to around $400 m...

Generics sales in the US, launch of inhalers in the UK and a ramp up from its acquisitions are key positive factors to look forward to.

In an email response seeking comment, PuraCap said its complaint was publicly available at the US District Court for the Southern District ...

Acquisitions of two companies in the US will help Cipla increase its foothold in the market and has made analysts bullish on the counter.

India Ratings & Research today said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based compan...

Cipla has acquired a portfolio of largely plain vanilla oral solids where its capabilities are already well-established, and hence the acqu...

Cipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.

Cipla on Friday fulfilled a longstanding desire to expand its beachhead in the US by buying Hetero Pharma’s US business for about $550 mill...

People close to the transaction said Cipla will buy Invagen and Camber, Hetero’s wholly owned subsidiary, for about $550 million.

Cipla shares climbed over 3% in morning trade after the company said its UK-based subsidiary, Cipla EU, will acquire two US-based companies.

Glenmark Pharmaceuticals Inc, US a subsidiary of Glenmark Pharmaceuticals has initiated the marketing and distribution of Nabumetone tablet...

Pharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc.